Clinical Trials in Cleveland

Showing 3241-3260 of 14,325 trials

Lupus Landmark Study: A Prospective Registry and Biorepository

NCT05934149

The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).

Systemic Lupus Erythematosus (SLE)Lupus NephritisNeuropsychiatric Systemic Lupus Erythematosus

Lupus Research Alliance3,500 participantsStarted Jun 2023

Birmingham, Alabama, United States • Tucson, Arizona, United States • Beverly Hills, California, United States +18 more locations

RECRUITINGPhase 1< 1 mile

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

NCT04429542

The investigational drug to be studied in this protocol, BCA101, is a first-in-class compound that targets both EGFR with TGFβ. Based on preclinical data, this bifunctional antibody may exert synergistic activity in patients with EGFR-driven tumors.

Head and Neck Squamous Cell CarcinomaSquamous Cell Carcinoma of Anal CanalColorectal Cancer+8 more

Bicara Therapeutics292 participantsStarted Jun 2020

La Jolla, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +17 more locations

Lupus Landmark Study: A Prospective Registry and Biorepository

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Find Trials by Condition in Cleveland

Surveillance Trial of the Apple Watch in Reliable Burden Assessment in Unseen Recurrence of Surgically Treated AF

Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer

A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma

Scaling Up Maternal Mental Healthcare by Increasing Access to Treatment (SUMMIT)

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Digital Single Session Intervention for Youth Mental Health

INSPIRE Trial for Abdominal Infections

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

Actis Total Hip System 2 Year Follow-up

Topical ENS-002 for Atopic Dermatitis in Adults

Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis